Merck & Co., Inc. (NYSE: MRK) reported its third quarter 2025 earnings results today.
Total worldwide sales of $17.3 billion were up 4% from the same period a year ago. Excluding the impact of foreign exchange, sales grew 3%.
GAAP net income increased 83% to $5.8 billion and EPS increased 87% to $2.32 compared to last year. Adjusted EPS rose 64% to $2.58.
For full-year 2025, the company now expects worldwide sales to be between $64.5-65.0 billion. Adjusted EPS is expected to be $8.93-8.98.
Prior performance
